Nephros (NEPH) Net Cash Flow Growth (3y) (2013 - 2026)
Powered by 
Analysis
Nephros (NEPH) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -9.45% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | -16.59% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | -0.80% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 60.16% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -85.83% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 43.26% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 1.60% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | -26.30% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 269.22% |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | 44.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.72% |
| Mar 31, 2026 | -106.78% |
| Dec 31, 2025 | 37.53% |
| Sep 30, 2025 | 34.00% |
| Jun 30, 2025 | 40.94% |
| Mar 31, 2025 | 30.20% |
| Dec 31, 2024 | 76.55% |
| Sep 30, 2024 | 12.38% |
| Jun 30, 2024 | -85.78% |
| Mar 31, 2024 | -102.64% |
| Dec 31, 2023 | -27.84% |
| Sep 30, 2023 | 32.30% |
| Jun 30, 2023 | 28.71% |
| Mar 31, 2023 | -65.21% |
| Dec 31, 2022 | -44.07% |
| Sep 30, 2022 | 19.43% |
| Jun 30, 2022 | -55.39% |
| Mar 31, 2022 | -16.87% |
| Dec 31, 2021 | -51.66% |
| Sep 30, 2021 | -35.79% |